arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ORTHOPEDIATRICS CORP

KIDS
$22.91 ▲ +0.03 (+0.13%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
12 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORTHOPEDIATRICS CORP faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $537.5M
Dividend Yield
Revenue Growth 15.4%
Op. Margin -16.6%
ROIC -8.8%
FCF / Share $-0.68
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity 0.31
info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$236.35M
↑ +15.4%
Net Income Profit after all expenses
$-39.65M
↓ -4.8%
Operating Margin Operating profit as % of sales
-16.6%
↑ +2.9% 11th
FCF / Share Free cash flow per share
$-0.68
↑ +62.0%
Long-Term Debt Long-term obligations
$106.01M
↑ +36.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
12
Returns
33
Financial Health
33
Cash Quality
36

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 41 quarters